Item 2. Unregistered Sales of Equity Securities
ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Private
Placement
On
January 14, 2021, we consummated a private placement of an aggregate 5,566,667 warrants (“Private Placement Warrants”) at
a price of $1.50 per Private Placement Warrant, generating total proceeds of approximately $8,350,000. The Private Placement Warrants,
which were purchased by our sponsor Global Partner Sponsor II, LLC are substantially similar to the warrants included in the units issued
in our Public Offering (the “Public Warrants”), except that if held by the original holder or their permitted assigns, they
(i) may be exercised for cash or on a cashless basis, (ii) are not subject to being called for redemption and (iii) are subject to certain
limited exceptions, will be subject to transfer restrictions until 30 days following the consummation of our initial business combination.
If the Private Placement Warrants are held by holders other than its initial holders, the Private Placement Warrants will be redeemable
by the Company and exercisable by the holders on the same basis as the Public Warrants. The sale of the Private Placement Warrants was
made pursuant to an exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended (“Securities
Act”).
Use
of Proceeds from the Initial Public Offering
On
January 14, 2021, we consummated our Public Offering of 30,000,000 units, with each unit consisting of one share of our Class A ordinary
shares and one detachable redeemable warrant (the “Detachable Redeemable Warrants”) and the contingent right to receive,
in certain circumstances, in connection with the business combination, one-sixth of one distributable redeemable warrant for each public
share that a public shareholder holds and does not redeem in connection with our initial business combination (the “Distributable
Redeemable Warrants” and together with the Detachable Redeemable Warrants, the Redeemable Warrants). Each whole Redeemable Warrant
offered in the Public Offering is exercisable to purchase one share of our Class A ordinary shares. Only whole Redeemable Warrants
may be exercised. Each whole Redeemable Warrant is exercisable to purchase one share ordinary share at an exercise price of $11.50 per
whole share. The warrants will become exercisable on the later of (i) 30 days after the completion of the initial business combination
and (ii) 12 months from the closing of the Public Offering. The warrants expire five years after the completion of the initial
business combination or earlier upon redemption or liquidation. Once the warrants become exercisable, the warrants will be redeemable
in whole and not in part at a price of $0.01 per warrant upon a minimum of 30 days’ notice if, and only if, the last sale price
of the Company’s Class A ordinary share equals or exceeds $18.00 per share for any 20 trading days within a 30 trading day period. The
Units in the Public Offering were sold at an offering price of $10.00 per unit, generating total gross proceeds of approximately $300,000,000. UBS
Investment Bank and RBC Capital Markets acted as joint book-runner managers for the Public Offering. The securities sold in the
Public Offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-251558). The SEC declared
the registration statement effective on January 11, 2021.
27
We
paid a total of approximately $6,000,000 in underwriting discounts and commissions and approximately $554,000 for other costs and expenses
related to the Public Offering. In addition, the underwriters for the Public Offering agreed to defer payment of approximately $10,500,000
in underwriting discounts and commissions, which amount will be payable upon consummation of our initial business combination, if consummated.
We also repaid the promissory note to our Sponsor from the proceeds of the Public Offering.
After
deducting the underwriting discounts and commissions (excluding the deferred portion of approximately $10,500,000 in underwriting discounts
and commissions, which amount will be payable upon consummation of our Business Combination, if consummated) and the offering expenses,
the total net proceeds from our Public Offering and the private placement of the Private Placement Warrants were approximately $301,471,000
of which approximately $300,000,000 (or $10.00 per unit sold in the Public Offering) was placed in the Trust Account. As of March
31, 2021, approximately $1.4 million was held outside the Trust Account and will be used to fund (a) the unpaid offering costs aggregating
approximately $70,000 and (b) the Company’s operating expenses. The proceeds held in the trust account may be invested by
the trustee only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S.
government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act. See also the Current
Report on Forms 8-K filed by the Company on January 21, 2021.
In
connection with the closing of the Public Offering a share recapitalization of 312,500 shares was made to the holders of 7,187,500 shares
of Class B ordinary share (increasing the total number of shares of Class B ordinary shares outstanding to 7,500,000) so that the initial
shareholders of the Company would collectively own 20.0% of the issued and outstanding ordinary shares of the Company after the Public
Offering.
ITEM
3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM
4. MINE SAFETY DISCLOSURES
None.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.